rs759178

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2099-25545A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 152,018 control chromosomes in the GnomAD database, including 25,312 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 25312 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.265

Publications

14 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.687 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.2099-25545A>C intron_variant Intron 13 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.2099-25545A>C intron_variant Intron 13 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1

Frequencies

GnomAD3 genomes
AF:
0.570
AC:
86615
AN:
151898
Hom.:
25274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.694
Gnomad AMI
AF:
0.355
Gnomad AMR
AF:
0.586
Gnomad ASJ
AF:
0.610
Gnomad EAS
AF:
0.615
Gnomad SAS
AF:
0.485
Gnomad FIN
AF:
0.485
Gnomad MID
AF:
0.567
Gnomad NFE
AF:
0.507
Gnomad OTH
AF:
0.602
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.570
AC:
86702
AN:
152018
Hom.:
25312
Cov.:
32
AF XY:
0.567
AC XY:
42181
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.694
AC:
28780
AN:
41480
American (AMR)
AF:
0.586
AC:
8943
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.610
AC:
2114
AN:
3466
East Asian (EAS)
AF:
0.614
AC:
3177
AN:
5174
South Asian (SAS)
AF:
0.485
AC:
2336
AN:
4818
European-Finnish (FIN)
AF:
0.485
AC:
5125
AN:
10564
Middle Eastern (MID)
AF:
0.562
AC:
164
AN:
292
European-Non Finnish (NFE)
AF:
0.507
AC:
34467
AN:
67936
Other (OTH)
AF:
0.605
AC:
1272
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1890
3779
5669
7558
9448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
732
1464
2196
2928
3660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.527
Hom.:
25867
Bravo
AF:
0.585
Asia WGS
AF:
0.582
AC:
2026
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
7.2
DANN
Benign
0.63
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759178; hg19: chr7-147575112; API